Kwality Pharmaceuticals Ltd. (KPL): Kwality Pharmaceuticals Share Price rises 8.15% as KPL trades at Rs 3,690
- September 8, 2026
- Posted by: Harsh Piplani
- Category: News
Kwality Pharmaceuticals Share Price rose to Rs 3,690, up 8.15% from the previous close of Rs 3,411.8, while market capitalisation stood at Rs 3,417.82 crore. The move places KPL among the stronger stocks in today’s Indian stock market and makes Kwality Pharmaceuticals Share Price Today a closely watched search term on Univest. The latest Univest data confirms the share price gain, but it does not establish a company-specific catalyst. For readers tracking Kwality Pharmaceuticals Stock News, the key issue is simple: the stock is trading higher, turnover is Rs 4.13 crore, and the price is holding near the day’s high of Rs 3,690 after opening at Rs 3,422.05. Investors monitoring Kwality Pharmaceuticals Share Price should focus on valuation, sector comparison and the next market update rather than assuming a single trigger.
Kwality Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,690 |
| Previous Close | Rs 3,411.8 |
| Today's Move | Rs 278.2 (+8.15%) |
| Open | Rs 3,422.05 |
| High | Rs 3,690 |
| Low | Rs 3,422.05 |
| Turnover | Rs 4.13 crore |
| Market Capitalisation | Rs 3,417.82 crore |
| Market Cap Category | Small Cap |
Kwality Pharmaceuticals Ltd. (KPL) rose to Rs 3,690 from the previous close of Rs 3,411.8, a move of Rs 278.2 or 8.15%. The stock opened at Rs 3,422.05, reached a high of Rs 3,690, recorded a low of Rs 3,422.05.
Kwality Pharmaceuticals Share Price Today shows a clear intraday gain of Rs 278.2, with the stock moving from Rs 3,422.05 at the open to Rs 3,690 at the latest trade. The day’s low was Rs 3,422.05 and the day’s high was Rs 3,690, so price action has stayed at the upper edge of the range. In plain terms, KPL is one of the Stocks Rising Today and a notable name among Top Gainers Today in Stock Market Today screens. The move is supported by Rs 4.13 crore turnover, which shows active interest without changing the basic fact that the article confirms a price rise, not a disclosed company event. For readers following Kwality Pharmaceuticals Share Price Live, today’s pattern is about firm price action and not a declared catalyst.
Kwality Pharmaceuticals Ltd. (KPL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 3,417.82 crore |
| P/E Ratio | 43.68x |
| P/B Ratio | 9.93x |
| ROE | 22.67% |
| ROCE | 24.01% |
| EPS | Rs 78.11 |
| Book Value Per Share | Rs 343.49 |
| Dividend Yield | 0% |
Kwality Pharmaceuticals Ltd. (KPL) fundamental metrics show P/E 43.68x, P/B 9.93x, ROE 22.67%, ROCE 24.01%. These figures provide context only and are not a buy or sell signal.
Kwality Pharmaceuticals Ltd. has a market capitalisation of Rs 3417.82 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 43.68x, P/B at 9.93x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 22.67% and ROCE of 24.01%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 78.11, book value per share of Rs 343.49, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.52x, median ROE of 11.82%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 43.68x |
| Benchmark Median P/E | 32.52x |
| Benchmark Average P/E | 49x |
| Benchmark P/E Range | 3.35x to 654.07x |
| Company P/B Ratio | 9.93x |
| Benchmark Median P/B | 3x |
| Company ROE | 22.67% |
| Benchmark Median ROE | 11.82% |
| Company ROCE | 24.01% |
| Benchmark Median ROCE | 13.71% |
| Company Market Capitalisation | Rs 3,417.82 crore |
| Benchmark Median Market Cap | Rs 701.65 crore |
Kwality Pharmaceuticals Ltd. (KPL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Kwality Pharmaceuticals Ltd. (KPL) has a P/E ratio of 43.68x, which is above the benchmark median of 32.52x, a difference of +34.32%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Kwality Pharmaceuticals Ltd. (KPL) has a ROE of 22.67%, which is above the benchmark median of 11.82%, a difference of +91.79%. Kwality Pharmaceuticals Ltd. (KPL) has a ROCE of 24.01%, which is above the benchmark median of 13.71%, a difference of +75.13%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,55,633.71 | 37.69 | 5.27 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,41,576.41 | 84.45 | 13.99 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 85.68 | 20.82 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,11,888.39 | 33.46 | 3.21 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,820.18 | 25.53 | 4.27 | 19.69 | 21.39 |
Kwality Pharmaceuticals Ltd. (KPL) has a P/E ratio of 43.68x compared with the displayed peer median of 37.69x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 22.67% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 24.01% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Kwality Pharmaceuticals Ltd. (KPL) has a market capitalisation of Rs 3,417.82 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Kwality Pharmaceuticals
- Kwality Pharmaceuticals Share Price rose 8.15% and traded near the day’s high, which keeps the stock on market screens.
- The latest Univest figures show market capitalisation at Rs 3,417.82 crore and turnover of Rs 4.13 crore.
- Kwality Pharmaceuticals Fundamental Analysis shows ROE of 22.67 and ROCE of 24.01, both above the industry median.
- Valuation remains richer than the industry median, with P/E at 43.68 and P/B at 9.93.
- The stock is drawing attention in Healthcare and Pharmaceuticals & Drugs sector watchlists on Univest.
About Kwality Pharmaceuticals
Kwality Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is followed by investors because its share price combines a mid-sized market capitalisation with a valuation profile that is higher than the industry median and return ratios that are stronger than the benchmark centre. Kwality Pharmaceuticals Share Price therefore tends to attract attention from readers comparing earnings power, accounting value and sector positioning. In practical terms, the company’s market profile is easier to read through the numbers than through broad market commentary: P/E is 43.68, P/B is 9.93, EPS is 78.11, and book value is Rs 343.49. The zero dividend yield suggests the stock is being assessed more for business performance and valuation than for current payout income. For investors using Univest, this is a straightforward healthcare name to monitor alongside larger pharmaceutical peers and broader market updates.
Frequently Asked Questions
Why is Kwality Pharmaceuticals Share Price rising today?
Ans. Kwality Pharmaceuticals Share Price rose 8.15% to Rs 3,690. The latest Univest figures confirm the move, but they do not establish a company-specific catalyst. Price action and market interest are the verified takeaways.
What is Kwality Pharmaceuticals Share Price today?
Ans. Kwality Pharmaceuticals Share Price today is Rs 3,690, compared with the previous close of Rs 3,411.8. That keeps KPL among the stronger gainers in today’s Indian stock market screens.
What is the market capitalisation of Kwality Pharmaceuticals?
Ans. Kwality Pharmaceuticals has a market capitalisation of Rs 3,417.82 crore. Market cap measures company size, not quality, so investors usually compare it with earnings ratios and sector benchmarks.
How does Kwality Pharmaceuticals compare with its industry valuation?
What do EPS and book value show for Kwality Pharmaceuticals?
Ans. EPS is 78.11 and book value is Rs 343.49 per share. EPS reflects earnings attributable to each share, while book value shows accounting net worth behind each share.
Does Kwality Pharmaceuticals offer a dividend yield?
Ans. Kwality Pharmaceuticals shows a dividend yield of 0. That means the current valuation is not being supported by an ongoing cash payout yield, so investors may focus more on earnings and return ratios.
How does Kwality Pharmaceuticals compare with healthcare peers?
Ans. Kwality Pharmaceuticals Share Price sits at a much smaller market cap than Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Cipla and Zydus Lifesciences. Its return ratios, however, are competitive against several listed peers.
Should investors track Kwality Pharmaceuticals Stock News on Univest?
Ans. Yes. Univest tracks Kwality Pharmaceuticals Stock News, Kwality Pharmaceuticals Share Price Live, valuation ratios and sector context. That makes it easier to monitor price action, company metrics and market updates in one place.
Track Kwality Pharmaceuticals Share Price on Univest
Use Kwality Pharmaceuticals Ltd. (KPL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Kwality Pharmaceuticals Share Price on Univest for live price updates, market cap, valuation ratios, company financials and sector context. Univest also helps users follow Kwality Pharmaceuticals Stock Analysis, Kwality Pharmaceuticals Share Price Update and broader Kwality Pharmaceuticals Latest News in one place. For a fuller view, keep an eye on key ratios, industry comparison and the stock’s next market move.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
